When researchers discover a new technology, its potential isn't always obvious. No one knew at first that email would become ...

WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins ...

EffiXTM is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a ...

It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the globe - EffiX™ delivers ...

Discover the world of therapeutic proteins, their applications, advantages, challenges, and future trends in healthcare and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Genetic technologies have the potential to help solve the ever-growing challenges of food insecurity and global health. But for this potential to be met, regulations that hinder scientific innovation ...

Eventually, participants hammered out safety protocols for laboratory work with recombinant DNA that went on to influence government regulations and still ... What's more, he says, the tools for ...

I was one of the first to spit into a test tube, giving up my DNA forever to learn more about my health and heredity. You know, the ones that promise to connect you with distant relatives you didn ...

As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's health biotech is approaching an inflection point.

Fifty years ago today, scientists met to set safety limits on the new field of genetic engineering. This week researchers meet again to discuss big questions as biotechnology grows more powerful.

The Global Recombinant DNA Technology Market was valued at approximately USD $$ billion in 2022 and is expected to grow at a healthy CAGR of over $% from 2023 to 2030. Recombinant DNA Technology ...